AI MARKET SCANNING

Beam Therapeutics Inc.

📅 Next Catalyst: Nov 03, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.20%
MAX GAP RECORD -11.25%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $BEAM
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 03, 2026 Earnings Release 2026-11-03 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 04, 2026 Earnings Release 2026-08-04 (BEFORE OPEN)
+3.16%
May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN)
-1.92%
Feb 24, 2026 Earnings Release 2026-02-24 (BEFORE OPEN)
+5.01%
Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN)
-4.66%
Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN)
-0.42%
May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN)
-2.62%
Feb 25, 2025 Earnings Release 2025-02-25 (BEFORE OPEN)
+4.25%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.2%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $BEAM

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease;…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗